Pharmacological evidence of muscarinic receptor heterodimerization

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 315-326

  Chiacchio, S ^a   Scarselli, M ^a   Armogida, M ^a   Maggio, R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Chimeric; Heterodimerization; Muscarinic; Pirenzepine; Tripitramine

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; CHIMERIC PROTEIN; DIAZEPINE DERIVATIVE; DIPITRAMINE; G PROTEIN COUPLED RECEPTOR; HEXAHYDROSILADIFENIDOL DERIVATIVE; MEMBRANE PROTEIN; METHOCTRAMINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; PIRENZEPINE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; ROCIVERINE; TRIPITRAMINE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DIMERIZATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STRUCTURE; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; GTP-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, MUSCARINIC;

EID: 0034125552     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00041-2     Document Type: Conference Paper

References (35)

1. Angeli P., Gualtieri F., Maggio R., Paparelli F., Scapecchi S. Affinity profiles at five cloned human muscarinic receptors (m1-m5) of a new series of antimuscarinic drugs. Pharm. Pharmacol. Lett. 3:1993;84-87.
2. Barbier P., Colelli A., Bolognesi M.L., Minarini A., Tumiatti V., Corsini G.U., Melchiorre C., Maggio R. Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor. Eur. J. Pharmacol. 355:1998;267-274.
3. Barbier P., Renzetti A.R., Turbanti L., Di Bugno C., Fornai F., Vaglini F., Maggio R., Corsini G.U. Stereoselective inhibition of muscarinic receptor subtypes by the eight stereoisomers related to rociverine. Eur. J. Pharmacol. 290:1995;125-132.
4. Barbier, P., Maggio, R., Colelli, A., Vaglini, F., Fornai, F., Corsini, G.U., 1996. Reconstitution of functional dopamine receptors by coexpression of N- and C-terminal receptor domains. Soc. Neuroci. Abstracts 26th Annual Meeting, 329, 1.
5. Blüml K., Mutschler E., Wess J. Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J. Biol. Chem. 269:1994;18870-18876.
6. Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:1987;527-532.
7. Bonner T.I., Young A.C., Brann M.R., Buckley N.J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1:1988;403-410.
8. Boxall D.K., Ford A.P.D.W., Choppin A., Nahorski S.R., Challiss R.A.J., Eglen R.M. Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea-pig isolated uterus. Br. J. Pharmacol. 124:1998;1615-1622.
9. Debburman S.K., Kunapuli P., Benovic J.L., Hosey M.M. Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membrane by G protein-coupled receptor kinases. Mol. Pharmacol. 47:1995;224-233.
10. Eglen R.M., Reddy H., Watson N., Challiss R.A.J. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol. Sci. 15:1994;114-119.
11. Fukamauchi F., Saunders P.L., Hough C., Chuang D.M. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells. Mol. Pharmacol. 44:1993;940-949.
12. 2-adrenergic receptor which exploits the domain structure of G-protein coupled receptors. J. Med. Chem. 40:1997;3871-3886.
13. Gouldson P.R., Snell C.R., Bywater R.P., Higgs C., Reynolds C.A. Domain swapping in G-protein coupled receptor dimers. Protein Eng. 11:1998;1181-1193.
14. Jakubik J., Wess J. Use of a sandwich enzyme-linked immunosorbent assay strategy to study mechanism of G protein-coupled receptor assembly. J. Biol. Chem. 274:1999;1349-1358.
15. BR2. Nature. 396:1998;674-679.
16. Jordan B.A., Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature. 399:1999;697-700.
17. Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
18. Kahn T.W., Engelman D.M. Bacteriorhodopsin can be refolded from two independently stable transmembrane helices and the complementary five-helix fragment. Biochemistry. 31:1992;6144-6151.
19. B-receptor subtypes assemble into functional heteromeric complexes. Nature. 396:1998;683-687.
20. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science. 240:1988;1310-1316.
21. Kubo T., Fukuda K., Mikami A., Maeda A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., Kangawa K., Kojima K., Matsuo H., Hirose T., Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 323:1986;411-416.
22. Liao M.J., London E., Khorana H.G. Regeneration of the native bacteriorhodopsin structure from two chymotryptic fragments. J. Biol. Chem. 258:1983;9949-9955.
23. Maggio R., Vogel Z., Wess J. Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett. 319:1993;195-200.
24. Maggio R., Vogel Z., Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein linked receptors. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3103-3107.
25. Maggio R., Barbier P., Bolognesi M.L., Minarini A., Tedeschi D., Melchiorre C. Binding profile of selective muscarinic receptor antagonist tripitramine. Eur. J. Pharm. 268:1994;459-462.
26. Maggio R., Barbier P., Fornai F., Corsini G.U. Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J. Biol. Chem. 49:1996;31055-31060.
27. Maggio R., Barbier P., Colelli A., Salvadori F., De Montis G., Corsini G.U. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J. Pharmacol. Exp. Ther. 291:1999;251-257.
28. Peralta E.G., Ashkenazi A., Winslow J.W., Smith D.H., Ramachandran J., Capon D.J. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6:1987;3923-3929.
29. Popot J.L., Gerchman S.E., Engelman D.M. Membrane folding and oligomerization: the two-stage model. J. Mol. Biol. 198:1987;655-676.
30. Schöneberg T., Liu J., Wess J. Plasma membrane localization and functional rescue of truncated forms of G protein-coupled receptor. J. Biol. Chem. 270:1995;18000-18006.
31. 2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J. 15:1996;1283-1291.
32. 3 receptor interactions. J. Pharmacol. Exp. Ther. 289:1999;464-476.
33. Weiner D.M., Levey A.I., Brann M.R. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. U.S.A. 87:1990;7050-7054.
34. B receptor. Nature. 396:1998;679-682.
35. Zholos A.V., Bolton T.B. Muscarinic receptor subtypes controlling the cationic current in guinea-pig ileal smooth muscle. Br. J. Pharmacol. 122:1997;885-893.